Bortezomib and Lenalidomide in Treating Patients With Relapsed or Refractory Mantle Cell Lymphoma
Clinical trial NCT00553644 · COMPLETED
Trial details
- NCT number
- NCT00553644
- Sponsor
- National Cancer Institute (NCI)
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-11-15
- Primary completion
- 2012-12-31
- Enrollment
- 53
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.